Works matching IS 03618609 AND DT 2016 AND VI 91 AND IP 8

Results: 26
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    High feasibility and antileukemic efficacy of fludarabine, cytarabine, and idarubicin (FLAI) induction followed by risk-oriented consolidation: A critical review of a 10-year, single-center experience in younger, non M3 AML patients.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 755, doi. 10.1002/ajh.24391
    By:
    • Guolo, Fabio;
    • Minetto, Paola;
    • Clavio, Marino;
    • Miglino, Maurizio;
    • Di Grazia, Carmen;
    • Ballerini, Filippo;
    • Pastori, Giordana;
    • Guardo, Daniela;
    • Colombo, Nicoletta;
    • Kunkl, Annalisa;
    • Fugazza, Giuseppina;
    • Rebesco, Barbara;
    • Sessarego, Mario;
    • Lemoli, Roberto Massimo;
    • Bacigalupo, Andrea;
    • Gobbi, Marco
    Publication type:
    Article
    15

    Early occurrence of red blood cell alloimmunization in patients with sickle cell disease.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 763, doi. 10.1002/ajh.24397
    By:
    • Sins, Joep W.R.;
    • Biemond, Bart J.;
    • Bersselaar, Sil M.;
    • Heijboer, H.;
    • Rijneveld, Anita W.;
    • Cnossen, Marjon H.;
    • Kerkhoffs, Jean-Louis H.;
    • Meurs, Alfred H.;
    • Ronnen, F.B.;
    • Zalpuri, Saurabh;
    • Rijke, Yolanda B.;
    • Ellen van der Schoot, C.;
    • Haas, Masja;
    • Bom, Johanna G.;
    • Fijnvandraat, Karin
    Publication type:
    Article
    16
    17
    18
    19
    20
    21

    Phase I study of evofosfamide, an investigational hypoxia-activated prodrug, in patients with advanced leukemia.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 800, doi. 10.1002/ajh.24415
    By:
    • Badar, Talha;
    • Handisides, Damian R.;
    • Benito, Juliana M.;
    • Richie, Mary Ann;
    • Borthakur, Gautam;
    • Jabbour, Elias;
    • Harutyunyan, Karine;
    • Konoplev, Sergej;
    • Faderl, Stefan;
    • Kroll, Stew;
    • Andreeff, Michael;
    • Pearce, Tillman;
    • Kantarjian, Hagop M.;
    • Cortes, Jorge E.;
    • Thomas, Deborah A.;
    • Konopleva, Marina
    Publication type:
    Article
    22
    23
    24
    25

    Final results of a single institution experience with a pediatric-based regimen, the augmented Berlin-Frankfurt-Münster, in adolescents and young adults with acute lymphoblastic leukemia, and comparison to the hyper-CVAD regimen.

    Published in:
    American Journal of Hematology, 2016, v. 91, n. 8, p. 819, doi. 10.1002/ajh.24419
    By:
    • Rytting, Michael E.;
    • Jabbour, Elias J.;
    • Jorgensen, Jeffrey L.;
    • Ravandi, Farhad;
    • Franklin, Anna R.;
    • Kadia, Tapan M.;
    • Pemmaraju, Naveen;
    • Daver, Naval G.;
    • Ferrajoli, Alessandra;
    • Garcia-Manero, Guillermo;
    • Konopleva, Marina Y.;
    • Borthakur, Gautam;
    • Garris, Rebecca;
    • Wang, Sa;
    • Pierce, Sherry;
    • Schroeder, Kurt;
    • Kornblau, Steven M.;
    • Thomas, Deborah A.;
    • Cortes, Jorge E.;
    • O'Brien, Susan M.
    Publication type:
    Article
    26